Cardif & Vale referred investigations

The procurement process involves Kettering General Hospital NHS Foundation Trust awarding a contract under the Health Care Services (Provider Selection Regime) Regulations 2023. The contract, titled "Cardif & Vale referred investigations," pertains to pathology services, specifically specialist testing provided by Cardiff & Vale to the biochemistry department at Kettering General Hospital. The procurement category is services, and it is located in the UKF2 region.

This particular stage of the process, tagged as 'award' and 'contract,' was completed on 2nd September 2025, with the contract made effective from 1st April 2025. The procurement method used was limited, following a direct award process without prior publication, reflecting a streamlined approach due to specific regulatory situations. This contract presents significant business opportunities for organisations involved in healthcare services, particularly those specialising in pathology or biochemistry testing.

The successful supplier, Cardiff and Vale University Health Board, exemplifies a large-scale entity well-suited for such contracts under the Provider Selection Regime. Businesses with expertise in niche areas of healthcare, particularly those capable of fulfilling specialised testing requirements, may find similar opportunities in this space, especially given the need for direct and efficient service provisions without the extensive competitive tendering process typically necessitated by public procurement. For companies aiming to expand within the healthcare industry, understanding and navigating unique procurement methods like those under the PSR can be a strategic advantage.